Harrow Health Inc
Change company Symbol lookup
Select an option...
HROW Harrow Health Inc
UPC Universe Pharmaceuticals Inc
MHH Mastech Digital Inc
GCTK GlucoTrack Inc
KODK Eastman Kodak Co
FYBR Frontier Communications Parent Inc
TPNEF Cub Energy Inc
ECC Eagle Point Credit Co LLC
CPHI China Pharma Holdings Inc
SHOP Shopify Inc
Go

Health Care : Pharmaceuticals | Small Cap Growth
Company profile

Harrow Health, Inc. is an ophthalmic-focused healthcare company. The Company's business specializes in the development, production and sale of medications that serve unmet needs in the marketplace through its subsidiaries and deconsolidated companies. The Company owns and operates ImprimisRx, an ophthalmology-focused pharmaceutical business, and Visionology, Inc. (Visionology), a direct-to-consumer eye care subsidiary focused on chronic eye disease. In addition, the Company holds non-controlling equity positions in Surface Ophthalmics, Inc. (Surface) and Melt Pharmaceuticals, Inc. (Melt). It also owns royalty rights in various drug candidates being developed by Surface and Melt.

Closing Price
$8.44
Day's Change
0.17 (2.06%)
Bid
--
Ask
--
B/A Size
--
Day's High
8.68
Day's Low
8.29
Volume
(Average)
Volume:
65,848

10-day average volume:
66,952
65,848

Cannabis stocks extend rally after report House planning to vote again on MORE Act that would legalize weed

8:42 am ET March 25, 2022 (MarketWatch)
Print

Cannabis stocks extended their late Thursday-rally premarket Friday, after a report that the U.S. House of Representatives is planning to vote for the second time on the Marijuana Opportunity, Reinvestment and Expungement (MORE) Act that would legalize cannabis at the federal level next week. The news was reported in a Thursday article in Marijuana Moment. The bill is one of a list that House leaders plan to take up on the House floor next week. An earlier version cleared the House last session but later stalled in what was a Republican-majority Senate. Canopy Growth Corp (WEED.T) was up 10% premarket. The Canadian company is poised to immediately benefit from U.S. legalization as it has an option to acquire multi-state operator Acreage Holdings once the law changes. Aurora Cannabis (ACB.T) was up 12%, Cronos Group Inc. (CRON.T) was up 7% and Tilray Brands Inc. (TLRY) was up 13.6%. The AdvisorShares Pure US Cananbis ETF (MSOS) was up 3.1% and the Cannabis ETF (THCX) was up 6.7%.

-Ciara Linnane

	

(END) Dow Jones Newswires

March 25, 2022 08:42 ET (12:42 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.